Cargando…

Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma

Accumulating studies have shown that methylation of tumor suppressor genes plays an important role in tumorigenesis. Deuterosome assembly protein 1 (DEUP1) has been implicated as a suppressor gene in some tumors and promoter methylation led to silencing of its expression. However, the roles of DEUP1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Qiwen, Cao, Shengli, Tang, Hongwei, Li, Jie, Guo, Wenzhi, Zhang, Shuijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607367/ https://www.ncbi.nlm.nih.gov/pubmed/31423198 http://dx.doi.org/10.3892/ol.2019.10421

Ejemplares similares

High expression of DHX9 promotes the growth and metastasis of hepatocellular carcinoma
por: Shi, Feng, et al.
Publicado: (2021)

Significance of Liver Zonation in Hepatocellular Carcinoma
por: Yu, Shizhe, et al.
Publicado: (2022)

Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma
por: Wang, Zhihui, et al.
Publicado: (2021)

FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo
por: Zhao, Kun, et al.
Publicado: (2022)

Single nucleotide polymorphisms in interleukin-6 attenuates hepatocytes injury in hypoxia/re-oxygenation via STAT3 signal pathway mediated autophagy
por: Tang, Hongwei, et al.
Publicado: (2021)

Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma
por: Guo, Wenzhi, et al.
Publicado: (2017)

Biophysical and biochemical properties of Deup1 self-assemblies: a potential driver for deuterosome formation during multiciliogenesis
por: Yamamoto, Shohei, et al.
Publicado: (2021)

Mitogen activated protein kinase phosphatase 5 alleviates liver ischemia–reperfusion injury by inhibiting TAK1/JNK/p38 pathway
por: Yu, Qiwen, et al.
Publicado: (2023)

Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma
por: Zhong, Dani, et al.
Publicado: (2017)

Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues
por: He, Yuting, et al.
Publicado: (2023)

miR-140-5p alleviates mouse liver ischemia/reperfusion injury by targeting CAPN1
por: Yu, Qiwen, et al.
Publicado: (2021)

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
por: Lv, Zhenbing, et al.
Publicado: (2013)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
por: Song, Min-Ae, et al.
Publicado: (2013)

An aberrant DNA methylation signature for predicting hepatocellular carcinoma
por: Zhang, Renhua, et al.
Publicado: (2020)

Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2017)

Myocardial protective effects of a c‐Jun N‐terminal kinase inhibitor in rats with brain death
por: Guo, Wenzhi, et al.
Publicado: (2016)

Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma
por: Hu, Bowen, et al.
Publicado: (2022)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)
por: DONG, YOUHONG, et al.
Publicado: (2014)

Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma
por: Huang, Peng, et al.
Publicado: (2021)

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14
por: Guo, Danfeng, et al.
Publicado: (2022)

ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway
por: Cui, Honglei, et al.
Publicado: (2021)

Aberrant regulation of Wnt signaling in hepatocellular carcinoma
por: Liu, Li-Juan, et al.
Publicado: (2016)

A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma
por: Dong, Yuting, et al.
Publicado: (2022)

Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma
por: Cai, Changzhou, et al.
Publicado: (2019)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Microarray Analysis For Expression Profiles of lncRNAs and circRNAs in Rat Liver after Brain-Dead Donor Liver Transplantation
por: Chen, Sanyang, et al.
Publicado: (2019)

Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition
por: Tang, Hongwei, et al.
Publicado: (2021)

Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma
por: Dong, Yuting, et al.
Publicado: (2023)

Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma
por: Sang, Liang, et al.
Publicado: (2018)

Genomic Aberrations in the HTPAP Promoter Affect Tumor Metastasis and Clinical Prognosis of Hepatocellular Carcinoma
por: Wu, Jin-Cai, et al.
Publicado: (2014)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2022)

E2F4’s cytoplasmic role in multiciliogenesis is mediated via an N-terminal domain that binds two components of the centriole replication machinery, Deup1 and SAS6
por: Hazan, Renin, et al.
Publicado: (2021)

Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis
por: Yang, Han, et al.
Publicado: (2017)

Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival
por: Guan, Renguo, et al.
Publicado: (2020)

Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma
por: Zhu, Lixu, et al.
Publicado: (2021)

Expression and Clinical Significance of Livin Protein in Hepatocellular Carcinoma
por: Guo, Hua, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_heekugqjfb3kqeerav22e8u2mp